Literature DB >> 14555609

Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz.

B D Roebuck1, Thomas J Curphey, Yuan Li, Karen J Baumgartner, Sridevi Bodreddigari, Jian Yan, Stephen J Gange, Thomas W Kensler, Thomas R Sutter.   

Abstract

Oltipraz and related dithiolethiones constitute an important class of chemopreventive agents that enhance the expression of carcinogen detoxication and antioxidant genes. Dose-response studies were undertaken to characterize the cancer chemopreventive activities of several dithiolethiones that are at least as active as oltipraz as inducers. Inhibition of formation of pre-neoplastic lesions and formation of DNA adducts in livers of rats exposed to aflatoxin B1 (AFB1) was monitored. In the tumorigenesis experiment, the dithiolethiones were orally gavaged 3 days/week for 3 successive weeks and at four doses ranging from 0.03 to 0.3 mmol/kg body wt. AFB1 was gavaged beginning 1 week after the start of the dithiolethiones and for two successive weeks. The burden of AFB1-induced putative pre-neoplastic lesions (glutathione S-transferase-placental isoform positive foci) was quantified by light microscopy. Reduction in AFB-DNA adduct burden was assessed 24 h following the first dose of AFB1. Both the parent 1,2-dithiole-3-thione (D3T) and its 5-tert-butyl derivative were more potent inhibitors than oltipraz against these endpoints, while two of the seven tested analogs were slightly less inhibitory. D3T, the most potent dithiolethione of this series, was examined by microarray analysis for induction of hepatic genes at an intermediate chemopreventive dose (0.1 mmol/kg). Transcript levels of eight genes, including two known to detoxify aflatoxin, namely, glutathione S-transferase A5 (GSTA5) and AFB1 aldehyde reductase (AFAR) were elevated. Western analysis indicated that induction of hepatic GSTA5 and AFAR were directly related to the dose of D3T. At the highest dose of D3T (0.3 mmol/kg), protein levels of GSTA5 and AFAR were induced by 7- and 27-fold, respectively. While efficacy in humans has yet to be tested, D3T is clearly more potent than oltipraz and serves as a useful molecular probe for determining the key events associated with protection by this class of agents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14555609     DOI: 10.1093/carcin/bgg173

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  12 in total

1.  Sulforaphane-mediated reduction of aflatoxin B₁-N⁷-guanine in rat liver DNA: impacts of strain and sex.

Authors:  Jeannette L A Fiala; Patricia A Egner; Nirachara Wiriyachan; Mathuros Ruchirawat; Kevin H Kensler; Gerald N Wogan; John D Groopman; Robert G Croy; John M Essigmann
Journal:  Toxicol Sci       Date:  2011-01-28       Impact factor: 4.849

2.  5MeCDDO Blocks Metabolic Activation but not Progression of Breast, Intestine, and Tongue Cancers. Is Antioxidant Response Element a Prevention Target?

Authors:  Ronald A Lubet; Reid Townsend; Margie L Clapper; M Margaret Juliana; Vernon E Steele; David L McCormick; Clinton J Grubbs
Journal:  Cancer Prev Res (Phila)       Date:  2016-05-05

3.  Lactone metabolite common to the carcinogens dioxane, diethylene glycol, and N-nitrosomorpholine: aqueous chemistry and failure to mediate liver carcinogenesis in the F344 rat.

Authors:  Niangoran Koissi; Niti H Shah; Brandon Ginevan; William S Eck; Bill D Roebuck; James C Fishbein
Journal:  Chem Res Toxicol       Date:  2012-04-12       Impact factor: 3.739

4.  Aflatoxin B1-DNA adduct formation and mutagenicity in livers of neonatal male and female B6C3F1 mice.

Authors:  Leslie L Woo; Patricia A Egner; Crystal L Belanger; Roongtiwa Wattanawaraporn; Laura J Trudel; Robert G Croy; John D Groopman; John M Essigmann; Gerald N Wogan; Jason T Bouhenguel
Journal:  Toxicol Sci       Date:  2011-04-19       Impact factor: 4.849

5.  log P estimation of 1,2-dithiole-3-thiones and 1,2-dithiole-3-ones: a comparison of experimental and calculative approaches.

Authors:  Sylvain Gargadennec; Gwenola Burgot; Jean-Louis Burgot; Raimund Mannhold; Roelof F Rekker
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

6.  Induced expression of drug metabolizing enzymes by preventive agents: role of the antioxidant response element.

Authors:  Ronald A Lubet; Ruisheng Yao; Clinton J Grubbs; Ming You; Yian Wang
Journal:  Chem Biol Interact       Date:  2009-08-18       Impact factor: 5.192

7.  Hydrogen peroxide is a second messenger in phase 2 enzyme induction by cancer chemopreventive dithiolethiones.

Authors:  Ryan Holland; Mettachit Navamal; Murugesan Velayutham; Jay L Zweier; Thomas W Kensler; James C Fishbein
Journal:  Chem Res Toxicol       Date:  2009-08       Impact factor: 3.739

8.  Transgenic expression of aflatoxin aldehyde reductase (AKR7A1) modulates aflatoxin B1 metabolism but not hepatic carcinogenesis in the rat.

Authors:  Bill D Roebuck; Denise N Johnson; Carrie Hayes Sutter; Patricia A Egner; Peter F Scholl; Marlin D Friesen; Karen J Baumgartner; Nicholas M Ware; Sridevi Bodreddigari; John D Groopman; Thomas W Kensler; Thomas R Sutter
Journal:  Toxicol Sci       Date:  2009-01-23       Impact factor: 4.849

Review 9.  Dithiolethiones for cancer chemoprevention: where do we stand?

Authors:  Yuesheng Zhang; Rex Munday
Journal:  Mol Cancer Ther       Date:  2008-11       Impact factor: 6.261

10.  Chemical genomics of cancer chemopreventive dithiolethiones.

Authors:  Quynh T Tran; Lijing Xu; Vinhthuy Phan; Shirlean B Goodwin; Mostafizur Rahman; Victor X Jin; Carrie H Sutter; Bill D Roebuck; Thomas W Kensler; E Olusegun George; Thomas R Sutter
Journal:  Carcinogenesis       Date:  2009-01-06       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.